Moderna COVID-19 Vaccine Overview and Safety

General Information
Name: mRNA-1273 Manufacturer: ModernaTX, Inc. Type of Vaccine: mRNA Number of Shots: 2 shots, 28 days apart Some immunocompromised people should get 3 shots. Booster Shot: Some groups of people are recommended to get a booster shot at least 6 months after getting their second shot. You can get any of the COVID-19 vaccines authorized in the United States for your booster shot. How Given: Shot in the muscle of the upper arm Does NOT Contain: Eggs, preservatives, latex, metals See Full List of Ingredients Below
Who Should Get Vaccinated
|
Who Should NOT Get Vaccinated
If you aren’t able to get an mRNA COVID-19 vaccine, you may still be able to get a different type of COVID-19 vaccine. Get more information for people with allergies. |
Moderna COVID-19 Vaccine Ingredients
All COVID-19 vaccine ingredients are safe. Nearly all of the ingredients in COVID-19 vaccines are ingredients found in many foods – fats, sugars, and salts. The Moderna COVID-19 vaccine also contains a harmless piece of messenger RNA (mRNA). The COVID-19 mRNA teaches cells in the body how to create an effective immune response to the virus that causes COVID-19. This response helps protect you from getting sick with COVID-19 in the future. After the body produces an immune response, it discards all of the vaccine ingredients, just as it would discard any information that cells no longer need. This process is a part of normal body functioning.
All COVID-19 vaccines are manufactured with as few ingredients as possible and with very small amounts of each ingredient. Each ingredient in the vaccine serves a specific purpose as seen in the table below.
Full list of ingredients
The Moderna COVID-19 Vaccine contains the following ingredients:
Type of Ingredient | Ingredient | Purpose |
Messenger ribonucleic acid (mRNA) |
| Provides instructions the body uses to build a harmless piece of a protein from the virus that causes COVID-19. This protein causes an immune response that helps protect the body from getting sick with COVID-19 in the future. |
Lipids (fats) |
| Work together to help the mRNA enter cells. |
Salt, sugar, acid stabilizers, and acid |
| Work together to help keep the vaccine molecules stable while the vaccine is manufactured, frozen, shipped, and stored until it is ready to be given to a vaccine recipient. |
Ingredients NOT used in COVID-19 vaccines
The above table lists ALL ingredients in the Moderna COVID-19 vaccine. There are NO ingredients in this vaccine beyond what is listed in the table. The Moderna COVID-19 vaccine has:
No preservatives like thimerosal or mercury or any other preservatives.
No antibiotics like sulfonamide or any other antibiotics.
No medicines or therapeutics like ivermectin or any other medications.
No tissues like aborted fetal cells, gelatin, or any materials from any animal.
No food proteins like eggs or egg products, gluten, peanuts, tree nuts, nut products, or any nut byproducts (COVID-19 vaccines are not manufactured in facilities that produce food products).
No metals like iron, nickel, cobalt, titanium, rare earth alloys, or any manufactured products like microelectronics, electrodes, carbon nanotubes or other nanostructures, or nanowire semiconductors.
No latex. The vial stoppers used to hold the vaccine also do not contain latex.
Possible Side Effects
In the arm where you got the shot:
| Throughout the rest of your body:
|
These side effects occur within a day or two of getting the vaccine. They are normal signs that your body is building protection and should go away within a few days.
Learn more about possible side effects after getting a COVID-19 vaccine. |
Other Authorized and Recommended COVID-19 Vaccines in the United States.
You should get a COVID-19 vaccination as soon as possible. All currently authorized and recommended COVID-19 vaccines are safe and effective, and CDC does not recommend one vaccine over another. CDC does not recommend mixing products for an initial 2-dose vaccine series or additional doses. Mixing and matching COVID-19 vaccines is allowed for booster shots. |
Safety Data Summary
In clinical trials, reactogenicity symptoms (side effects that happen within 7 days of getting vaccinated) were common, but were mostly mild to moderate. Few people had reactions that affected their ability to do daily activities.
Side effects throughout the body (such as fever, chills, tiredness, and headache) were more common after the second dose of the vaccine.
Cases of myocarditis and pericarditis in adolescents and young adults have been reported more often after getting the second dose than after the first dose of one of the two mRNA COVID-19 vaccines, Pfizer-BioNTech or Moderna. These reports are rare, and the known and potential benefits of COVID-19 vaccination outweigh the known and potential risks, including the possible risk of myocarditis or pericarditis.
CDC will continue to provide updates as we learn more about the safety of the Moderna vaccine in real-world conditions.
Learn more about vaccine safety monitoring after a vaccine is authorized or approved for use. |
Clinical Trial Demographic Information
Clinical trials for the Moderna vaccine included people from the following racial, ethnic, age, and sex categories:
Race
79% White
10% African American
5% Asian
<3% other races/ethnicities
<1% American Indian or Alaska Native
<1% Native Hawaiian or Other Pacific Islander
Ethnicity
79% not Hispanic or Latino
20% Hispanic or Latino
1% unknown
Sex
53% male
47% female
Age
75% 18 through 64 years
25% 65 years and older
Twenty-two (22%) of people who participated in the clinical trials had at least one condition that put them at risk of severe illness from COVID-19. The most frequent underlying medical conditions among participants were lung disease, heart disease, obesity, diabetes, liver disease, or HIV infection. Four percent (4%) of participants had two or more high-risk conditions. Most people who participated in the trials (82%) were considered to have an occupational risk of exposure, with 25% of them being healthcare workers.
Learn more about demographic information for people who participated in the trials. |